TruAlt Bioenergy to sell Unit 5 to Onkar Agro for ₹171 crore, board approves Aug. 4, 2026
TruAlt Bioenergy's board approved a ₹171 crore slump sale of a non-core, zero-revenue unit that carries ~₹135 crore of IREDA term debt. The transaction, if completed, would deconsolidate the liability and reduce interest expense, improving EBIT and operating cash flow while freeing capital for core operations. As a single-company corporate action, broader market impact is limited, with focus on balance-sheet quality and execution risk through closing.
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
TruAlt Bioenergy said its board on August 4, 2026 approved the sale of its non-core Unit 5 to Onkar Agro for ₹171 crore. The unit currently generates no revenue and carries about ₹135 crore of debt, while its net assets are valued at ₹159.32 crore, or 10.53% of the company’s net worth as of March 31, 2026. The company said the transaction will help it shed the associated debt, lower finance costs and improve EBIT and operating cash flow.